RJA
ZBH icon

Ross\Johnson & Associates’s Zimmer Biomet ZBH Stock Holding History

Ross\Johnson & Associates’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.97K Sell
55
-1
-2% -$92 0.09% 49
2025
Q4 		$5.04K Buy
56
+1
+2% +$95 0.09% 50
2025
Q3 		$5.42K Hold
55
– – 0.1% 47
2025
Q2 		$5.02K Hold
55
– – 0.1% 44
2025
Q1 		$6.22K Hold
55
– – 0.11% 74
2024
Q4 		$5.81K Buy
+55
New +$5.9K 0.13% 40

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ross\Johnson & Associates's ZBH Position: Q1 2026 in Review

Ross\Johnson & Associates reduced its Zimmer Biomet (ZBH) stake by 1.8% in Q1 2026, selling an estimated $92 and leaving 55 shares worth $4.97K. The position accounts for 0.09% of the portfolio, ranked #49.

Ross\Johnson & Associates first reported a position in ZBH in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.22K in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Ross\Johnson & Associates held 55 shares of Zimmer Biomet worth $4.97K as of Q1 2026.
  • Ross\Johnson & Associates sold 1 Zimmer Biomet share in Q1 2026, an estimated $92.
  • Zimmer Biomet made up 0.09% of Ross\Johnson & Associates's portfolio in Q1 2026, its #49 holding.
  • Ross\Johnson & Associates first reported a position in Zimmer Biomet in Q4 2024 and has held it in 6 quarters since.
  • Ross\Johnson & Associates's Zimmer Biomet position peaked at $6.22K in Q1 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.